Match each clinical presentation of a localized skin and soft tissue infection with the most appropriate empiric oral antimicrobial therapy.
- A 45-year-old woman presents with a rapidly expanding, sharply demarcated, brilliantly erythematous, and raised plaque on her right cheek accompanied by sudden-onset fever.Oral penicillin V
- A 28-year-old man presents with a 4-centimeter, fluctuant, exquisitely tender erythematous nodule on his posterior thigh with surrounding induration.Oral trimethoprim-sulfamethoxazole
- A 62-year-old man presents with poorly demarcated, flat, spreading erythema and warmth over his left lower extremity without any purulent drainage or fluctuance.Oral cephalexin
- A 19-year-old male athlete presents with a deep, erythematous, and tender puncture wound on the plantar aspect of his foot sustained while wearing rubber-soled athletic shoes.Oral ciprofloxacin
Cevap
Erysipelas matches with oral penicillin V; purulent abscesses match with oral trimethoprim-sulfamethoxazole; non-purulent cellulitis matches with oral cephalexin; and sneaker-associated puncture wounds match with oral ciprofloxacin.
Empiric antimicrobial stewardship requires matching the clinical phenotype to the most likely pathogen profile. Group A Strep (erysipelas) requires penicillin. Mixed Strep/MSSA (non-purulent cellulitis) requires cephalexin. MRSA (purulent abscess) requires trimethoprim-sulfamethoxazole. Pseudomonas (sneaker puncture) requires ciprofloxacin.
Adım Adım Çözüm
Anahtar Kavram
Selection of empiric oral antibiotics for skin and soft tissue infections is strictly guided by the clinical phenotype (purulent vs. non-purulent) and specific environmental exposures.